BIOMAT Database Logo BIOMAT Database Logo

Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China. 2013

Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

OBJECTIVE The aim of the study was to determine the seroprevalence and epidemiological features of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection among patients newly diagnosed with HIV/AIDS in China. METHODS Two thousand and forty patients newly diagnosed with HIV/AIDS from 10 provinces in China were selected during 2009 to 2010. Serum samples obtained from each individual were screened for HBV and HCV serum markers [HBV surface antigen (HBsAg), HBV surface antibody (HBsAb), HBV envelope antigen (HBeAg), HBV envelope antibody (HBeAb), HBV core antibody (HBcAb) and HCV antibody (HCVAb)]; liver function tests were also performed. Demographics and medical histories were collected. RESULTS Of the 2040 patients, 741 (36.3%) were positive for at least one HBV and HCV serum marker; 300 (14.71%) were HCVAb positive, and 248 (12.16%) were isolated HCVAb positive; 222 (10.9%) were positive for HBsAg; 19 (0.93%) were positive for both HBsAg and HCVAb. The highest prevalence of HBsAg positivity was found in Guangxi (15.31%), followed by Guangdong (15.19%) and Shanghai (14.36%). The highest prevalence of HCVAb positivity was found in Xinjiang (43.18%), followed by Henan (39.06%) and Yunnan (27.36%). The proportion of patients with abnormal liver function in patients positive for HCVAb and/or HBsAg was significantly higher than that in those who were negative for both HCVAb and HBsAg (P < 0.001). CONCLUSIONS The seroprevalence of HBV and HCV among patients newly diagnosed with HIV/AIDS in China is high. HBsAg and HCVAb positivity prevalences were found to vary significantly in different provinces in China. Patients newly diagnosed with HIV/AIDS and coinfected with HBV and HCV are at higher risk of abnormal liver function. It is necessary to routinely screen for HBV and HCV infection among patients newly diagnosed with HIV/AIDS.

UI MeSH Term Description Entries
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III

Related Publications

Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
[Radioimmunological survey of serological markers of viral hepatitis].
January 1983, Giornale di batteriologia, virologia ed immunologia,
Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
Multiple viral coinfections among HIV/AIDS patients in China.
January 2011, Bioscience trends,
Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
[Serological markers for viral hepatitis, type B, among patients with neuropsychological diseases].
January 1979, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
[Serological markers in viral hepatitis].
July 1990, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
[Serological markers of arthritis in patients with chronic viral hepatitis].
April 2006, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
Serological markers of hepatitis B and C in patients with HIV/AIDS and active tuberculosis.
June 2016, Journal of medical virology,
Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana.
July 2019, BMC research notes,
Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
[Serological markers of viral hepatitis].
January 1993, Revista de gastroenterologia de Mexico,
Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
Serological survey of markers of infection with viral hepatitis among the Yukpa Amerindians from western Venezuela.
December 1996, Annals of tropical medicine and parasitology,
Y Z Shen, and Z Y Wang, and T K Qi, and X Y Jiang, and W Song, and Y Tang, and J R Wang, and L Liu, and R F Zhang, and Y F Zheng, and Z S Dai, and H Z Lu
HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study.
March 2019, AIDS research and therapy,
Copied contents to your clipboard!